Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : Health.am > Health Centers > Endocrinology -
Study uncovers blood clot risk in hormone therapy Study uncovers blood clot risk in hormone therapy

Study uncovers blood clot risk in hormone therapy

EndocrinologyOct 05, 2004

A widely publicized study that has already linked hormone replacement therapy to an increased risk of stroke, heart attack and some cancers also uncovered a blood clot hazard, researchers reported on Tuesday.

The study, called the Women’s Health Initiative, found that women taking estrogen plus progestin at the strength once commonly in use had a doubled risk of venous blood clots, which can travel to the lungs and cause death. 

The estrogen-progestin combination is most often sold in the United States as Wyeth’s Prempro. The U.S. Food and Drug Administration now recommends that women seeking relief from menopausal symptoms should use such drugs at the lowest effective dose and for the shortest time necessary.

Wyeth in the years since 2002 when the study results began to emerge has introduced two lower strength versions of Prempro.

The blood clot data, reported by researchers at the University of Vermont in Colchester, came from the study that involved 16,608 postmenopausal women between the ages of 50 and 79 recruited from 1993 through 1998. Some women received the hormone drug while others got an inert placebo.

The study found that the blood clot risk was highest for those who were overweight, and that a genetic disposition for clots as well as advancing age also increased the risk. Taking aspirin to thin the blood did not counteract the problem, it said.

“The implications of these findings may be important for the use of postmenopausal hormone therapy in the treatment of menopausal symptoms among younger postmenopausal women,” the researchers concluded.

The American College of Obstetricians and Gynecologists said recently that more research is needed into whether hormone replacement therapy may be safer for younger women.

SOURCE: Journal of the American Medical Association, October 6, 2004.

Provided by ArmMed Media
Revision date: July 5, 2011
Last revised: by Amalia K. Gagarina, M.S., R.D.

Study uncovers blood clot risk in hormone therapy Bookmark this! Study uncovers blood clot risk in hormone therapy

RELATED STORIES:


 Comments [ + Post Your Own

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]




We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

Please enter the word you see in the image below:


   [advanced search]   
What health info have you recently searched for online?
Disease or condition
Exercise or fitness
Diet, nutrition or vitamins
None of the above


Get free support - Headache Causes, Symptoms, Diagnosis, and Treatment on HeadacheCare.net


Health Centers







Diabetes

















Health news
  


Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools



   Health newsletter

  





   Medical Links



   RSS/XML News Feed



   Feedback


Add to Yahoo RSS News Feed



Google Reader




Syndicate


This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
Verify here.




Recurrent Depression. All about mental disorders and depression

hit counter